NeoPharm CO., LTD. (KOSDAQ:092730)
21,450
-750 (-3.38%)
Nov 20, 2026, 3:30 PM KST
| Market Cap | 335.50B +19.0% |
| Revenue (ttm) | 132.18B +11.1% |
| Net Income | 27.82B +20.6% |
| EPS | 1,778.81 +20.6% |
| Shares Out | 15.64M |
| PE Ratio | 12.06 |
| Forward PE | 8.70 |
| Dividend | 750.00 (3.50%) |
| Ex-Dividend Date | Dec 29, 2026 |
| Volume | 35,752 |
| Open | 22,000 |
| Previous Close | 22,200 |
| Day's Range | 21,350 - 22,200 |
| 52-Week Range | 15,590 - 26,000 |
| Beta | 0.51 |
| Analysts | Strong Buy |
| Price Target | 30,500.00 (+42.19%) |
| Est. Earnings | Feb 5, 2027 |